August 7, 2020
UK- based healthcare scale-up, Navenio, has announced that the Royal Cornwall NHS trust has selected its location-based AI platform to support Clinical Imaging Assistants (CIAs) within the radiology portering and service support teams.
This move is part of a programme of efficiency improvements within the diagnostic imaging department.
WHY IT MATTERS
The partnership involves supporting the trust...
August 3, 2020
Israeli "digital X-ray" startup Nanox filed a Form F-1 with the SEC on Friday that outlines plans to raise $125 million in an IPO.
The company has applied to list its shares on the Nasdaq exchange as "NNOX," and according to a representative has entered its quiet period prior to the IPO.
Nanox, which has raised $110 million from investors since November 2019, is building a two-part offering...
July 28, 2020
Israeli "digital X-ray" startup Nanox has secured another $59 million from unnamed "global investors."
The company now pegs its round total at $110 million, after combining today's news with investments announced since November of 2019. Contributors to those incremental raises included Foxconn, Fujifilm and SK Telecom.
WHAT IT DOES
The Israeli company is developing a two-pronged offering...
July 23, 2020
Spain-based medtech company, QUIBIM, have secured €8 million in a recent round of seed funding co-led by Amadeus Capital Partners and Adara Ventures to improve its radiomics platform.
WHAT IT DOES
QUIBIM is a frontrunner in the field of radiomics, which uses artificial intelligence (AI) to read medical images for disease-specific biomarkers, enabling early detection of diseases such as COVID-19....
July 2, 2020
Mumbai-based healthcare AI startup Qure.ai earlier this week announced its first US FDA 510(k) clearance for its head CT scan product qER. The US Food and Drug Administration’s decision covers four critical abnormalities identified by Qure.ai’s emergency room product.
The AI tool can now be used to triage radiology scans with intracranial bleeds, mass effect, midline shift, and cranial fractures...
March 5, 2020
SymphonyAI Group, a collection of private B2B artificial intelligence companies spanning multiple sectors, announced yesterday that it has acquired TeraRecon, the maker of products for medical-image post-processing and other related products.
As the group’s seventh portfolio company, TeraRecon will continue building out its radiology, cardiology and vascular-surgery AI-imaging support. However,...
February 27, 2020
Mumbai-based healthcare AI startup Qure.ai announced that has raised $16 million in funding led by Sequoia India and was supported by MassMutual Ventures Southeast Asia. The fresh funds will be used for geographical expansion, product portfolio expansion and to support regulatory clearances.
Qure.ai was founded in 2016 by co-founders Prashant Warier (who is also CEO) and Pooja Rao (who is also R...
November 25, 2019
Nines, a tele-radiology and artificial intelligence startup, unveiled its software platform alongside news of a $16.5 million Series A raise. The funding was led by Accel and 8VC, with individual participants also taking part.
WHAT THEY DO
The two-year-old startup’s efforts are broken into two camps. On the one hand is a tele-radiology service that’s staffed by live specialists, and according to...
June 17, 2019
The past week has seen two FDA clearances awarded to Israeli companies building artificial intelligence analysis tools for medical imaging.
The first, announced last Tuesday, was Aidoc’s tool for triaging cervical spine fractures. Much like the company’s prior offerings, the new product analyzes images to prioritize high-risk cases for review by a radiologist, and does so within the specialist’s...
May 15, 2019
Aidoc, an Israeli provider of artificial intelligence products for radiologists, announced today that it has received FDA clearance for a tool that identifies potential cases of pulmonary embolism — a blockage in one of the lung’s pulmonary arteries — for expert review.
“We chose to focus on this product because these are patients who might not necessarily have clear symptoms of pulmonary...